Kuopio, Finland – Oy Medfiles Ltd, a renowned contract research organization in Finland, proudly announces the successful completion of the sale of its R&D and Analytical service business to Eurofins BioPharma Product Testing Finland Oy, effective as of 28 February 2025.
This strategic transaction signifies Medfiles’ commitment to enhancing its focus on core services, including Regulatory Affairs, Pharmacovigilance, and Clinical Study services, while ensuring that its laboratory operations continue to flourish under Eurofins’ esteemed leadership.
Executive Comments:
“We are excited about this transaction, which allows Medfiles to sharpen its focus on our core business areas, Regulatory Affairs, Pharmacovigilance, and Clinical study services, while ensuring that the laboratory services continue to thrive under Eurofins’ leadership,” said Norifumi Ninokata, CEO of Medfiles.
“We believe this move will benefit our clients by providing them with access to an even broader range of high-quality analysis and testing services provided by the broader Eurofins network of laboratories,” commented Mirja Savolainen, Managing Director of Eurofins BioPharma Product Testing Finland Oy.
About Medfiles:
Medfiles is a leading contract research organization with over 37 years of experience providing Regulatory affairs, Pharmacovigilance, and Clinical study, primarily in the European market. Headquartered in Finland, Medfiles serves clients in the pharmaceutical, biotechnology, medical device, food, feed, and cosmetic industries across the globe. The parent company of Medfiles is WDB Holdings, which is listed on the Tokyo Stock Exchange Prime Market (Securities Code: 2475).
About Eurofins:
Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.
For media inquiries, please contact:
Norifumi Ninokata
CEO
Oy Medfiles Ltd.
Email:
Mirja Savolainen
Managing Director
Eurofins BioPharma Product Testing Finland Oy:
Email:
